Burkina Faso vs Kenya: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Burkina Faso
0.7%
in 2024
Kenya
0.7%
in 2024
Burkina Faso rank
51st
Kenya rank
51st
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Burkina Faso
- Kenya
How they compare
Burkina Faso currently reports 0.7% against 0.7% in Kenya, a difference of 0.0%.
Across all 10 years both countries report, Kenya has been ahead every year.
Burkina Faso ranks 51st and Kenya ranks 51st of 246 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 1.1% | 0.1% | Kenya |
| 2020s | 0.8% | 0.9% | 0.1% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Burkina Faso or Kenya?
- Burkina Faso, at 0.7% against 0.7% in Kenya as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Burkina Faso and Kenya?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Kenya?
- 10 years are reported by both, from 2015 to 2024.
- How do Burkina Faso and Kenya rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Burkina Faso ranks 51st and Kenya ranks 51st of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.